KTCAN-DT Tablets – Ketorolac Tromethamine 10 mg Dispersible Tablets

KTCAN-DT Tablets by Amcare Pharmaceuticals contain Ketorolac Tromethamine IP 10 mg, a non-steroidal anti-inflammatory drug (NSAID) used for the short-term management of moderately severe acute pain.

The product is supplied as an uncoated dispersible tablet, designed to be dispersed in water before administration as directed by the physician.

---

Composition of KTCAN-DT Tablets

Brand: KTCAN-DT
Generic: Ketorolac Tromethamine
Strength: 10 mg
Dosage form: Uncoated dispersible tablet
Route: Oral
Pack size: 10 × 10 Tablets
Company: Amcare Pharmaceuticals
Category: Prescription NSAID

---

What are KTCAN-DT Tablets Used For?

KTCAN-DT contains ketorolac, an NSAID intended for the short-term management of moderately severe acute pain. Official labeling specifically states that oral ketorolac is not intended for minor or chronic painful conditions.

It may be prescribed in situations such as:

• Moderately severe acute pain
• Short-term postoperative pain
• Acute musculoskeletal pain where a physician considers ketorolac appropriate
• Other clinically appropriate acute-pain situations under medical supervision

The exact indication should be determined by the treating physician.

Not intended for:

• Routine daily pain management
• Long-term chronic pain
• Minor aches and pains
• Unsupervised self-medication

Ketorolac treatment should be transitioned to an alternative analgesic when appropriate rather than continued beyond the recommended duration.

---

How Does KTCAN-DT Work?

Ketorolac Tromethamine

Ketorolac works by inhibiting cyclooxygenase (COX) enzymes, reducing the production of prostaglandins involved in pain and inflammation.

This produces:

• Analgesic action
• Anti-inflammatory activity
• Reduction in pain associated with acute inflammatory conditions

Ketorolac is particularly used for its analgesic effect in moderately severe acute pain.

---

Dosage & Administration

Take KTCAN-DT only according to the prescription of a qualified healthcare professional.

Because ketorolac has important dose- and duration-related safety risks, the dose should not be increased without medical advice.

How to take a dispersible tablet

The product packaging indicates that the tablet is intended to be dispersed in water before administration. Follow the instructions provided on the approved product label or by the physician/pharmacist.

Duration of treatment

This is particularly important with ketorolac:

The total duration of ketorolac therapy in adults should not exceed 5 days, including any IV/IM ketorolac given before oral tablets.

Do not continue KTCAN-DT beyond the prescribed duration even if pain persists; consult the treating physician for an alternative approach.

---

Benefits / Therapeutic Role

1. Strong Analgesic Action

Ketorolac provides analgesic activity for appropriately selected patients with moderately severe acute pain.

2. NSAID-Based Pain Management

It reduces prostaglandin production involved in pain and inflammation.

3. Dispersible Dosage Form

KTCAN-DT is supplied as a dispersible tablet that can be dispersed in water before administration according to the product instructions.

4. Short-Term Acute Pain Management

Ketorolac is specifically positioned for short-term acute pain, rather than chronic pain treatment.

---

Possible Side Effects

Possible adverse effects include:

• Indigestion
• Nausea
• Vomiting
• Stomach discomfort
• Abdominal pain
• Headache
• Dizziness
• Drowsiness
• Diarrhea
• Constipation
• Increased risk of bleeding
• Kidney function changes
• Fluid retention

Ketorolac can cause serious gastrointestinal complications including ulceration, gastrointestinal bleeding and perforation, which can occur even without warning symptoms.

---

Serious Side Effects – Seek Medical Attention

Stop taking the medicine and seek urgent medical attention if symptoms suggest:

Gastrointestinal bleeding

• Black/tarry stools
• Vomiting blood
• Severe abdominal pain

Allergic reaction

• Facial or throat swelling
• Difficulty breathing
• Severe rash

Cardiovascular symptoms

• Chest pain
• Sudden weakness
• Shortness of breath

Kidney problems

• Markedly reduced urine output
• Significant swelling
• Sudden unexplained weight gain

Ketorolac’s serious gastrointestinal and renal risks mean that even short-term treatment requires appropriate medical supervision.

---

Precautions & Warnings

1. Maximum 5-Day Treatment

This is the most important safety consideration.

Ketorolac tablets should not be used for more than 5 days in adults, because longer exposure increases the frequency and severity of adverse reactions.

2. Gastrointestinal Risk

Ketorolac can cause:

• Peptic ulcers
• GI bleeding
• GI perforation

These complications can be serious or fatal and may occur without warning.

3. Kidney Function

Ketorolac can adversely affect kidney function, particularly in patients who are dehydrated or have pre-existing renal impairment.

4. Bleeding Risk

Ketorolac inhibits platelet function and can increase bleeding risk. Particular caution is required in patients with bleeding disorders or those taking anticoagulant medicines.

5. Cardiovascular Risk

Like other NSAIDs, ketorolac can increase the risk of cardiovascular events, particularly with higher doses or longer exposure.

---

Who Should Not Take KTCAN-DT?

Ketorolac is contraindicated or unsuitable in patients with certain conditions, including:

• Active peptic ulcer disease
• Recent gastrointestinal bleeding or perforation
• Previous significant peptic ulcer/GI bleeding
• Previous allergic reaction to ketorolac
• Asthma, urticaria or allergic-type reactions triggered by aspirin or other NSAIDs
• High risk of bleeding
• Certain cerebrovascular bleeding conditions
• Severe renal impairment
• Patients already taking aspirin or other NSAIDs
• Patients receiving probenecid
• Patients receiving pentoxifylline

The official labeling specifically lists several of these as contraindications.

---

Drug Interactions

Inform the doctor about all medicines being taken.

Particular caution is required with:

• Aspirin
• Other NSAIDs
• Warfarin and other anticoagulants
• Antiplatelet medicines
• Corticosteroids
• ACE inhibitors
• Angiotensin receptor blockers
• Diuretics
• Lithium
• Methotrexate
• Probenecid
• Pentoxifylline
• Other medicines affecting kidney function

Important

Do not combine KTCAN-DT with another NSAID unless specifically instructed by a physician.

The official labeling specifically contraindicates concurrent use with aspirin or other NSAIDs because of the cumulative risk of serious NSAID adverse effects.

---

KTCAN-DT During Pregnancy & Breastfeeding

Ketorolac should not be used during pregnancy unless specifically determined appropriate by a healthcare professional.

Ketorolac is contraindicated during labor and delivery, because prostaglandin inhibition can affect fetal circulation and uterine contractions and may increase the risk of maternal bleeding.

Pregnancy or breastfeeding should always be discussed with the treating physician before use.

---

Driving & Operating Machinery

KTCAN-DT may cause dizziness or drowsiness in some patients.

Avoid driving or operating machinery if you experience these effects.

---

Storage

Store KTCAN-DT Tablets:

• In a cool, dry place
• Away from direct sunlight
• Protected from excessive moisture
• Out of reach of children

Follow the storage conditions printed on the final approved product packaging.

---

Key Product Features

---

Why Choose KTCAN-DT by Amcare Pharmaceuticals?

KTCAN-DT provides Ketorolac Tromethamine IP 10 mg in a dispersible tablet formulation intended for physician-directed short-term management of appropriate acute pain.

The product is designed for use within the established safety limitations of ketorolac therapy, particularly regarding treatment duration, gastrointestinal risk, kidney function and bleeding risk.